Position in ILMN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$102,285,585
+$64,522,789 QoQ
Shares Held
581,730
+89.9% QoQ
Ownership
0.385%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#51
of 932 holders
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Alyeska Investment Group, L.P. holds $929,620,379 across 10 Diagnostics & Research names. ILMN ranks #4 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
401,082 | $211,145,608 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
376,071 | $188,546,956 | |
| 3 | A |
Agilent Technologies, Inc.
|
814,971 | $108,252,597 | |
| 4 | ILMN |
Illumina, Inc.
This page
|
581,730 | $102,285,585 | |
| 5 | GH |
Guardant Health, Inc.
|
647,818 | $97,192,134 | |
| 6 | RDNT |
RadNet, Inc.
|
1,171,721 | $72,260,034 | |
| 7 | DHR |
Danaher Corp /De/
|
310,000 | $59,048,800 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
235,000 | $53,295,650 |
All Filings in ILMN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,285,585 | 581,730 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $37,762,796 | 306,367 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $112,312,261 | 806,609 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $103,494,997 | 542,455 | Shares | Sole | 2022-11-14 | |
| 2020-12-31 | $25,553,681 | 69,064 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||